{"id":"W2793122709","doi":"10.1016/j.clinthera.2017.12.015","title":"An Observational Study of Concomitant Use of Emerging Therapies and Denosumab or Zoledronic Acid in Prostate Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Amgen","keywords":"Medicine; Enzalutamide; Denosumab; Cabazitaxel; Prostate cancer; Zoledronic acid; Concomitant; Abiraterone acetate; Internal medicine; Oncology; Docetaxel; Cohort; Population; Cancer; Androgen deprivation therapy; Osteoporosis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014296,0.0004806087,0.001165879,0.0006779349,0.0008045665,0.001393531,0.0008882187,0.001262085,0.001614713],"category_scores_gemma":[0.00557267,0.000942893,0.002435143,0.002258584,0.0005188123,0.0008400985,0.0007880608,0.001819119,0.0002950826],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006895646,"about_ca_system_score_gemma":0.001244595,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01302123,"about_ca_topic_score_gemma":0.01269014,"domain_scores_codex":[0.9975988,0.0007831694,0.0004503617,0.0005840671,0.0003110441,0.0002725152],"domain_scores_gemma":[0.9922293,0.001681593,0.003978407,0.0008918947,0.0004706387,0.0007481803],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003940239,0.0002642348,0.9926695,0.00006960177,0.001661105,0.0001236701,0.00007492789,0.00005302842,0.0003851553,0.00003811535,0.0001172473,0.0006032264],"study_design_scores_gemma":[0.0003556103,0.001100606,0.9958461,0.00002583051,0.001059412,0.0004258244,0.0002587927,0.0003333174,0.0001003033,0.00005263236,0.0004219531,0.00001979378],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974632,0.001350809,0.0001162542,0.00005981967,0.00003037553,0.0000169306,0.0007267714,0.000003548759,0.0002322077],"genre_scores_gemma":[0.9987621,0.0002626503,0.00009545343,0.00007746755,0.0000394683,0.00001434543,0.0006169464,0.000002798499,0.0001288539],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01302123,"threshold_uncertainty_score":0.02589089,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.5229752836077713,"score_gpt":0.5422627704409436,"score_spread":0.01928748683317227,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}